Dark

SGMO
Sangamo Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Mar 13, 2026 3:59:51 PM EDT

0.3800USD-3.560%(-0.0141)4,073,037

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Mar 13, 2026 9:25:30 AM EDT

0.3961USD0.000%(0.0000)19,565

After-hours

Mar 13, 2026 4:56:30 PM EDT

0.3707USD-2.958%(-0.0113)80,100

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

142.43M

CEO

Alexander Macrae

Headquarters

Brisbane, California, USA

Industry

Biotechnology

Next Earnings

Mar 16, 2026 (today)

AMGN BMRN SHPG GILD BIIB ALNY PDLI JNJ MRK DWDP XLV

SGMO Stats

Avg. Vol. 10 Day

3,280,129

Avg. Vol. 30 Day

6,085,983

Employees

209

Market Cap

142,429,608

Shares Out.

371,684,781

On/Off Exchange

31%/69%

6 Month Beta

3.29

1 Year Beta

1.31

2 Year Beta

1.72

3 Year Beta

1.68

52 Week Low

0.35

52 Week High

1.04

SMA50

0.41

SMA200

0.50

1 Week

-6.58%

1 Month

+3.57%

3 Month

-12.91%

6 Month

-23.41%

1 Year

-60.95%

2 Year

-50.87%

5 Year

-96.76%

Profile

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

SGMO Stock Summary

Sangamo Therapeutics, Inc. Common Stock (NASDAQ:SGMO) stock price today is $0.3800, and today's volume is 4,073,037. SGMO is down -3.560% today. The 30 day average volume is 6,085,983. SGMO market cap is 142.43M with 371,684,781 shares outstanding.